How does dasatinib stop leukemia cells from growing?
Dasatinib blocks a faulty protein called BCR-ABL that makes leukemia cells divide uncontrollably. By shutting down this protein at the nanomolar level, dasatinib stops cancer cell growth and allows your bone marrow to make healthy blood cells again [1][4].
Dasatinib inhibits BCR-ABL kinase and five other kinases (SRC, LCK, YES, FYN, c-KIT) at nanomolar concentrations. In the DASISION trial, 90% of treatment-naïve CML patients achieved complete cytogenetic response within 12 months—meaning leukemia cells dropped to undetectable levels in bone marrow [4]. This is the gold standard for CML control.
Inside your leukemia cells, BCR-ABL is a broken protein that tells cells to divide forever. Dasatinib fits into the kinase pocket like a key in a lock, blocking the signal. Your immune system then clears out the damaged cells, and your bone marrow starts making normal white blood cells, red blood cells, and platelets again [1][9].
Most patients feel better within 2–6 weeks as their blood counts recover. Energy returns, bruising stops, and infections become less frequent. However, dasatinib works only if you take it every single day—missing doses allows leukemia to come back. Your oncologist will check your blood counts monthly to confirm the drug is working and adjust your dose if side effects appear [4][9].
Set a phone alarm for the same time every morning to take dasatinib. Take it with a full glass of water, with or without food. If you miss a dose, take it as soon as you remember—unless it's almost time for your next dose. Never double up. Call your oncology clinic if you miss more than one dose in a week.